Hygiene and health company Essity has secured a EUR 400m loan at favorable terms with the European Investment Bank (EIB). The loan has a tenor of 7 years and will support the company’s research, development, and innovation initiatives across all business areas.
“The agreement with the European Investment Bank supports Essity’s aim to further strengthen the innovation capabilities across the Group. From value‑enhancing upgrades to breakthrough product launches, we are committed to combining sustainability and performance to deliver innovations that truly build a difference and raise the bar for hygiene and health”, declares Ulrika Kolsrud, President and CEO of Essity.
Essity’s innovation process combines deep consumer insights with advanced technologies to develop solutions that improve well-being, enhance customer value and strengthen competitiveness while also reducing environmental impact.
“Europe’s competitiveness depfinishs on sustained investment in innovation that improves people’s everyday lives. By supporting Essity’s research and innovation programme, with a strong base in Sweden, the EIB is strengthening Europe’s technological leadership in hygiene and health while advancing the green transition and the circular economy,” declares Karl Nehammer, Vice-President of the European Investment Bank.
The European Investment Bank is the long-term lfinishing institution of the European Union, owned by its Member States. A core mission of the bank is to strengthen EU competitiveness, technological innovation and sustainable development by providing financing for R&D projects conducted within Europe.
Contact information
Per Lorentz, Vice President Corporate Communications, Tel: 073 313 30 55, per.lorentz@essity.com
Sandra Åberg, Vice President Investor Relations, Tel: 070 564 96 89, sandra.aberg@essity.com
Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are utilized by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actishift, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2025, Essity had net sales of approximately SEK 138bn (EUR 13bn) and employed 36,000 people. The company’s headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.
Leave a Reply